This bill amends Minnesota Statutes to modify the requirements for access to epinephrine in schools. Key changes include the replacement of the term "auto-injectors" with "delivery systems" throughout the relevant sections, specifically in sections 121A.22, 121A.2205, and 121A.2207. The bill clarifies that students may possess epinephrine delivery systems if their parents and prescribing medical professionals provide written notification to the school. Additionally, it establishes that schools must develop individualized health plans for students requiring epinephrine, which may be included in a student's 504 plan, and outlines the responsibilities of school staff in recognizing anaphylaxis and administering epinephrine.

Furthermore, the bill allows schools to maintain a stock supply of epinephrine delivery systems and permits registered nurses to administer these systems in cases of anaphylaxis, regardless of whether the individual has a prescription. It also enables schools to enter into arrangements with manufacturers for the supply of epinephrine delivery systems and mandates the commissioner of health to provide a standing order for distribution. Overall, the bill aims to enhance the safety and accessibility of epinephrine for students with life-threatening allergies in educational settings.

Statutes affected:
Introduction: 121A.22, 121A.2205, 121A.2207
1st Engrossment: 121A.22, 121A.2205, 121A.2207